Project: Development and validation of an EPIgenetics-based THYroid cancer DIAgnostic

The consortium will develop an innovative epigenetic-based diagnostic kit for the detection of thyroid cancer. The kit will be based on a promising set of DNA methylation markers. In this project, these biomarkers will be developed into an actual IVD kit that will be analytically and technically validated, and subsequently tested in a proof-of principle study. Directly after this project, the consortium will perform larger scale validation studies.

Acronym EPITHYDIA (Reference Number: 10580)
Duration 01/10/2016 - 01/10/2019
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 5

Project partner

Number Name Role Country
24560 Diagenode S.A Coordinator Belgium
24561 Austrian Institute of Technology GmbH Partner Austria
24562 Platomics GmbH Partner Austria